{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:35:56Z","timestamp":1734500156134,"version":"3.30.2"},"reference-count":0,"publisher":"Knowledge E DMCC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJHOSCR"],"abstract":"<jats:p>A-64-year old male presented with cough, weight loss, and maculopapular rash for 15-20 days. On examination, he was found to have cervical lymphadenopathy and splenomegaly. His leukocyte count was 62.1x109\/L, platelets were 1169x109\/L and LDH was 816 IU\/L. Peripheral blood film showed a leukoerythroblastic picture with thrombocytosis. He was started on hydroxyurea and allopurinol. Subsequently, bone marrow evaluation was done which depicted increased lymphoid cells with an M:E ratio of 4:1. Cellular areas exhibited an increase in myeloid precursors along with prominent lymphoid cells and abundant megakaryocytes. Immunohistochemistry showed an increase in B-lymphocytes. Grade MF-2 reticulin fibrosis was noted. Overall findings suggested essential thrombocythemia (ET). On flow cytometry, CD45-positive lymphoid cells population was 31% and showed reactivity to Pan-B-markers with lambda light chain restriction. Janus Kinase 2 (JAK 2) mutation was detected while BCR-ABL1 translocation was negative. A diagnosis of ET progressing to myelofibrosis and mature B-lymphoproliferative disorder was made. Hydroxyurea and allopurinol were stopped while ruxolitinib was introduced and 2.5 years later he remains stable on this treatment.<\/jats:p>","DOI":"10.18502\/ijhoscr.v15i4.7481","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T06:24:21Z","timestamp":1634624661000},"source":"Crossref","is-referenced-by-count":0,"title":["Concomitant Essential Thrombocythemia and Mature B -Lymphoproliferative Disorder in a Patient"],"prefix":"10.18502","author":[{"given":"Ayesha","family":"Butt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruhul","family":"Quddus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7770","published-online":{"date-parts":[[2021,10,17]]},"container-title":["International Journal of Hematology-Oncology and Stem Cell Research"],"original-title":[],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T16:41:28Z","timestamp":1734453688000},"score":1,"resource":{"primary":{"URL":"https:\/\/ec2-18-184-16-47.eu-central-1.compute.amazonaws.com\/index.php\/IJHOSCR\/article\/view\/7481"},"secondary":[{"URL":"https:\/\/ijhoscr.tums.ac.ir\/index.php\/ijhoscr\/article\/view\/1338","label":"UNIVERSITY"},{"URL":"https:\/\/publish.kne-publishing.com\/index.php\/IJHOSCR\/article\/view\/7481","label":"PUBLISHER"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,17]]},"references-count":0,"URL":"https:\/\/doi.org\/10.18502\/ijhoscr.v15i4.7481","relation":{},"ISSN":["2008-2207"],"issn-type":[{"type":"electronic","value":"2008-2207"}],"subject":[],"published":{"date-parts":[[2021,10,17]]}}}